| Hans-Günter Meyer-Thompson | Fachartikel
A Need for Benzodiazepine Deprescribing in the COVID-19 Pandemic: A Cohort Study.
A Need for Benzodiazepine Deprescribing in the COVID-19 Pandemic: A Cohort Study.
Bužančić I, Pejaković TI, Hadžiabdić MO.
Pharmacy (Basel). 2022 Sep 23;10(5):120. doi: 10.3390/pharmacy10050120. PMID: 36287441; PMCID: PMC9611451.